The WNT Signaling Pathway Effector TCF7L2 Mediates Olanzapine-Induced Weight Gain and Insulin Resistance
Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2018.00379
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 16, 2018
Authors
Publisher
Frontiers Media SA